Cholesterol and Lipoprotein Metabolism Flashcards

1
Q

What is the basic structure of lipoprotein?

A

polar surface coat (phospholipid, free cholesterol) and nonpolar lipid core (cholesterol ester, triglyceride) + apolipoproteins (embedded proteins)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Purpose of lipoprotein

A

transport cholesterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Difference between triglycerides and phospholipids

A

phospholipids have 2 FA tails + phosphate –> polar

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Lipoproteins with the largest diameter have the highest/lowest density

A

lowest –> will float (e.g. chylomicrons and chylomicron remants)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Which lipoprotein is it in: ApoB

A

chylomicrons (48), VLDL, IDL, LDL(100) AKA everything except HDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Which lipoprotein is it in: ApoA1

A

HDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which lipoprotein is it in:ApoE

A

VLDL, HDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Which lipoprotein is it in:ApoCII

A

chylomicrons, VLDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Exogenous pathway for lipoprotein metabolism

A

fats come from intestine –> TG in chylomicrons –> lymph (aka bypass liver) –> lipoprotein lipase in tissues consumes TG –> frees FA for tissues + releases chylomicron remant (w/ApoE)–> LDLR on liver for cholesterol recylcing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is a required cofactor for lipoprotein lipase?

A

ApoCII

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Endogenous pathway of lipoprotein metabolism

A

FFA in liver adipose packaged in VLDL (B100) and released to blood –> consumed by LPL –> IDL remnant (intermediate) –> further metabolism to LDL (B100) –> LDLR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How does DM2 or insulin resistance contribute to hyperlipidemia?

A

increased adipose lipolysis –> higher liver production of TG –> overproduction of VLDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Why don’t most diabetics have high ldl?

A

there is often a secondary breakdown in LPL that leaves everything at the VLDL stage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Etiology: Familial chylomicronemia syndrome

A

mutations in LPL or ApoCII lead to reduced breakdown of chylomicrons and result in chylomicronemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Presentation of FCS

A

eruptive xanthomas, pancreatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Etiology: Familial dysbetalipoproteinemia

A

After breakdown of chylomicron, chylomicron remant takes on ApoE which provides docking with the liver (also involved in VLDL remant/IDL uptake)

–> if you have homozyogous ApoE2 instead of 3 or 4, you get buildup of remants of chylomicrons and VLDL

17
Q

Presentation of FD

A

xnathomata over elbows, palmar xanthomas, CHD

18
Q

Etiology: Familial hypercholesterolemia

A

mutations in LDLR prevent docking of LDL and disrupts cholesterol metabolism –> LDL buildup

can be heterozyogous or homozygous (worse)

19
Q

Presentation of FH

A

corneal arcus, xanthelasma, tendon xanthoma (very specific for FH), CHD, normal TG

*significant cutaneous xanthomas in homozyogous FH

20
Q

What’s the difference between FH and FDB

A

familial defective apoB-100 involves mutation in apoB in the docking strip for LDLR –> same presentation but different mutation

21
Q

Etiology: Autosomal dominant hypercholesterolemia 3 (ADH3)

A

increased pcsk9 negatively regulates LDL receptor

22
Q

Gain of function or loss of function in Pcsk9 cause severe hypercholesterolemia

A

gain of function

23
Q

Etiology: Familial hypertriglyceridemia

A

VLDL metabolism breaks down

24
Q

Clinical presentation of FHTG

A

high VLDL and triglycerides –> if type 5 (severe) severe eruptive xanthomas, pancreatitis, CHD

25
Q

What is type 5 FHTG?

A

it is an advanced form that results in high VLDL AND high chylomicrons

26
Q

Etiology: Familial combined hyperlipidemia FCHL

A

combined disorder leading to overproduction of VLDL (like in DM2 but have normal LPL) –> high VLDL, high IDL, high LDL

27
Q

Clinical presentation of FCHL

A

CHD, high V/I/LDLs

28
Q

What is Lp(a)

A

independent risk factor for CHD, highly genetically determined, unknown function, homologous to plasminogen –> bound to ApoB and hangs off the particle

29
Q

What is the relationship between HDL and CHD?

A

inverse

30
Q

HDL structure

A

TG/CE core with phospholipids + ApoA1

31
Q

What is the reverse cholesterol transport pathway

A

HDL interacts with cells like macrophages and promote cholesterol efflux from cells and transports esterified cholesterol back to liver for excretion in bile

32
Q

Primary genetic causes of low HDL (hypoalphalipoproteinemia)

A
ApoA1 mutation - rapid catabolism
Tangier disease (ABCA1) - cholesterol transport from macrophages to HDL broken down
LCAT deficiency - breakdown of cholesterol ester formation in HDL molecules
33
Q

Is there a causal link between HDL and coronary disease

A

not clear –> but independent risk factor for CHD risk

34
Q

Clinical finding in LCAT deficiency

A

cloudy cholesterol buildup on cornea

35
Q

Clinical finding in Tangier disease

A

large orange tonsils